The big China CRO WuXi Biologics is slated for an initial public offering of up to $513 million in Hong Kong.

PPD has expanded its vaccine sciences lab in Richmond, Virginia, by another 17,000 square feet and added vaccine efficacy testing capacity using cell-based…

Charles River Laboratories has beefed up its library of patient-derived xenografts (PDXs) by adding new genetic characteristics into the mix.

DelMar is advancing its first-in-class brain cancer med dianhydrogalactitol (VAL-083) into phase 3, and it has recruited PRA Health Sciences to conduct that…

CRO Clinigen is teaming up with biotech Tesaro and its PARP ovarian cancer med niraparib to help launch an early access program in Europe, coming after the…

Activist investor Starboard Value is demonstrating its confidence in Parexel by disclosing a 5.7% stake buy in the company, immediately after news of the CRO’s…

PPD has put its medical affairs research operations team under Evidera, the evidence-based solutions subsidiary PPD bought last year.

WIRB-Copernicus Group continued an acquisition spree with purchases of electronic clinical outcome assessments specialists MedAvante and ProPhase.

Quintiles and IMS Health came together last year in a massive $19 billion megamerger, and now INC and inVentiv are looking to follow suit, combining into one…

CRO